Oxford Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,416
Closed -$874K 662
2025
Q3
$874K Buy
+10,416
New +$858K 0.29% 89
2024
Q4
Sell
-4,806
Closed -$546K 549
2024
Q3
$546K Sell
4,806
-1,319
-22% -$157K 0.45% 64
2024
Q2
$758K Buy
+6,125
New +$789K 0.74% 27
2024
Q1
Sell
-4,778
Closed -$521K 324
2023
Q4
$521K Buy
+4,778
New +$496K 0.78% 38
2019
Q4
Sell
-70,444
Closed -$5.66M 1967
2019
Q3
$5.66M Sell
70,444
-130,453
-65% -$10.5M 0.14% 186
2019
Q2
$16.1M Buy
200,897
+138,462
+222% +$10.6M 0.35% 34
2019
Q1
$4.96M Buy
62,435
+39,137
+168% +$2.93M 0.11% 215
2018
Q4
$1.7M Buy
23,298
+19,931
+592% +$1.41M 0.04% 555
2018
Q3
$227K Buy
+3,367
New +$215K ﹤0.01% 1569
2017
Q4
Sell
-188,462
Closed -$11.5M 1775
2017
Q3
$11.5M Buy
188,462
+25,738
+16% +$1.56M 0.22% 54
2017
Q2
$9.95M Buy
162,724
+147,377
+960% +$8.97M 0.2% 72
2017
Q1
$930K Buy
+15,347
New +$931K 0.02% 838

Other funds holding MRK

Oxford Asset Management's MRK Position: Q4 2025 in Review

Oxford Asset Management sold out of Merck (MRK) in Q4 2025, closing a stake of 10,416 shares — an estimated $874K sold.

Oxford Asset Management first reported a position in MRK in Q1 2017 and held it in 12 quarters. The position peaked at $16.1M in Q2 2019. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Oxford Asset Management reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Oxford Asset Management sold 10,416 Merck shares in Q4 2025, an estimated $874K.
  • Oxford Asset Management first reported a position in Merck in Q1 2017 and held it in 12 quarters.
  • Oxford Asset Management's Merck position peaked at $16.1M in Q2 2019.
  • 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Oxford Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.